Abstract:Objective To explore the clinical significance of multidrug resistance (MDR1) expression and its correlation with P 53 in esophageal carcinoma.Methods The expression of MDR1 by in situ hybridization in 57 esophageal carcinomas and the expression of P 53 by immunohistochemistry in 44 of 57 esophageal carcinomas were analyzed,and then evaluated their relationship with clinicopathological factors and their correlation.Results The positive expression rate of MDR1mRNA was 35%in 57 esophageal carcinomas.Eight positive expression cases (29%) were found in 28 cases without lymph node metastasis,and 12 positive expression cases (41%) were found in 29 cases with lymph node metastasis;Eight positive expression cases (27%) were found in 30 clinical II stage cases,and 12 positive expression cases (44%) were found in 27 clinical III-IV stage cases.No significant correlation was found among MDR1mRNA expression and tumor size,position,differentiation degree and infiltration degree.The positive expression rate of mutation P 53 was 73%in 44 esophageal carcinomas.Five positive expression cases (45%) were found in 11 cases that tumor cells invaded to muscle,and 27 positive expression cases (41%) were found in 33 cases that tumor cells invaded to serous membrane.Significant difference between them was found(P 0.01).No significant correlation was found among mutation P 53 expression and tumor size,position,differentiation degree,lymph node metastasis state and clinical stage.Ten MDR1mRNA positive expression cases were found in 32 P 53 positive expression cases,no significant correlation between them(P 0.01).Conclusion Over expressions of MDR1mRNA and mutation P 53 were significantly associated with esophageal carcinoma progression.The expression of MDR1mRNA might not be regulated by mutation P 53.

The Expression Study of MDM2 and P53 in Oral Verrucous Carcinoma

Immunohistochemical Analysis of P57(kip2), P53 and Hsp60 Expressions in Premalignant and Malignant Oral Tissues

Expressions of P53 and Nm23 Proteins in Oral Squamous Cell Carcinoma

Expression and Significance of MDM2 Mrna and P53 Protein in Squamous Cell Carcinoma of the Vulva

Expression of MDR1mRNA detected and its correlation with p53 in esophageal carcinoma by in situ hybridization

The Study of C-erbB-2 and Nm23 Protein in Oral Squamous Cell Carcinoma

Expression of P53, Mdm2, P21, Heat Shock Protein 70, and Hpv 16/18 E6 Proteins in Oral Verrucous Carcinoma and Oral Verrucous Hyperplasia

Expressions of p53 and hMSH2 in colon carcinoma

THE CORRELATION BETWEEN MDM2 EXPRESSION AND P53 MUTATION IN HUMAN LUNG CANCER

Expression of MDC1 Protein in Oral Squamous Cell Carcinoma and Its Clinical Significance

[Expressions of PDCD5 and P53 in Oral Leukoplakia and Oral Squamous Cell Carcinoma].

The Expression of P16, P53 and Ki-67 Protein in Epithelial Dysplasia from Oral Mucosa and a Follow-Up Study of Four Years

A clinicopathological study on verrucous hyperplasia and verrucous carcinoma of the oral mucosa.

p16 and p53 Gene Expression in Oral Squamous Cell Carcinomas

The Expression of the Mdm2 Gene May Be Related to the Aberration of the P53 Gene in Human Hepatocellular Carcinoma

Association of P53 and MDM2 Polymorphisms with Risk of Human Papillomavirus (Hpv)-Related Esophageal Squamous Cell Carcinoma (ESCC).

Effects of p14ARF-MDM2-p53 Cell Cycle Regulation Pathway on the Carcinogenesis of Cervical Squamous Cell Carcinoma

Integrating Mcm-2 and Ki-67 immunohistochemistry with clinico-pathologic parameters for enhanced prognostic accuracy in oral verrucous lesions

Research on miRNA-195 and target gene CDK6 in oral verrucous carcinoma

The Related Study of High Risk HPVI6、18 Infection and Expression of Multiple Genes in Oral Squamous Cell Carcinomas

[Expression and correlation of HPV16E6 and tumor suppressor gene p53 in oral squamous cell carcinoma]